At least one-third of the world's population has been infected with the hepatitis B virus (HBV), and 400 million people are chronic carriers. In most populations, chronic HBV infection is the ...

HDV was discovered in patients infected with hepatitis B virus (HBV). It generally makes HBV infections more damaging to the liver. It is a subviral satellite agent that depends upon HBV envelope ...

Background Hepatitis B virus (HBV) is a common cause of viral hepatitis with significant health complications including cirrhosis and hepatocellular carcinoma. Assays for hepatitis B surface ...

Chronic hepatitis B (CHB) is a long-term infection of the liver caused by the hepatitis B virus (HBV). While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the ...

Hepatitis B is a liver inflammation caused by the hepatitis B virus (HBV). It is the second-leading infectious cause of death globally after tuberculosis. Prevention of mother-to-child ...

The company is dedicated to educating patients, providers, and others on new findings in chronic hepatitis B virus (HBV) infection. Chronic HBV infection is the most common viral infection in ...

As a briefer, hepatitis B is a virus that affects the liver and results ... This is significant on the background of an ...

The majority of children and adults who receive the hepatitis B (hep B) virus vaccine do not need a booster. The six hepatitis B vaccines licensed for use in the United States afford lifelong ...

DelveInsight’s, “Chronic Hepatitis B Virus Pipeline Insight 2025” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Chronic Hepatitis B Virus pipeline ...

An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...

“I want to encourage everyone to go and get tested for hepatitis B. Even if you already know your status, don’t be deceived into thinking the virus is inactive. You need to check at least ...

Shares of Precision BioSciences DTIL rallied 23.8% on Tuesday after the company’s announcement that the FDA has granted Fast Track designation to PBGENE-HBV. This is DTIL’s lead, fully owned ...